Show simple item record

dc.contributor.authorPennay, Amy
dc.contributor.authorLubman, D.
dc.contributor.authorReichert, T.
dc.contributor.editorSteve Allsop
dc.contributor.editorNicole Lee
dc.date.accessioned2017-01-30T14:59:11Z
dc.date.available2017-01-30T14:59:11Z
dc.date.created2015-03-03T20:14:25Z
dc.date.issued2012
dc.identifier.citationPennay, A. and Lubman, D. and Reichert, T. 2012. Opportunistic interventions for methamphetamine use: reducing the risksin Allsop, S. and Lee, N. (ed), Perspectives on Amphetamine-Type Stimulants, pp. 241-253. Australia: IP Communications.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/42356
dc.description.abstract

Methamphetamine is the third most popular illicit drug in Australia. Over one million (6.3%) Australians report having ever tried methamphetamine, and approximately 3% are regular users (AHIW 2008). Around 11 % of regular users are likely to develop dependence to methamphetamine (equating to 73 000 Australians) (McKetin et al 2005a), underscoring the need for early detection and effective management of methamphetamine-related harms. However, methamphetamine users are less likely than other drug users to access specialist alcohol and other drug (AOD) treatment for their drug use (AIHW 2007; Klee & Morris 1994; Pennay & Lee 2009; Shearer & Gowing 2004; Wright et al 1999), highlighting the important role that other healthcare professionals (e.g. general practitioners (GPs), hospital staff and mental health workers) must play in the treatment of methamphetamine use/dependence. In this chapter, we discuss Steven, a methamphetamine user who presents to his local GP with problems related to methamphetamine use. In describing this case, important clinical and treatment issues are explored.

dc.publisherIP Communications
dc.titleOpportunistic interventions for methamphetamine use: reducing the risks
dc.typeBook Chapter
dcterms.source.startPage241
dcterms.source.endPage253
dcterms.source.titlePerspectives on Amphetamine-Type Stimulants
dcterms.source.isbn9780980864991
dcterms.source.placeAustralia
dcterms.source.chapter28
curtin.departmentNational Drug Research Institute (NDRI)
curtin.accessStatusFulltext not available


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record